The Attitudes of Students (Biomedical Engineering) Towards Chat GPT

Document Type : Original paper


1 Department of Biomedical Engineering, Hygiene Faculty, Medical Branch, Islamic Azad University, Tehran, Iran

2 Department of Biology, Avicenna International College, Budapest, Hungary


Background and aim: This study explores the attitudes of biomedical engineering students towards ChatGPT, a natural language processing model developed by OpenAI. The aim is to understand the extent of its application and integration within the academic landscape, particularly in the field of medical engineering.
Methods: A survey of 150 biomedical engineering students, mostly from Iran, was conducted between May 28 and September 19, 2023. It gathered demographic data, assessed familiarity with ChatGPT, and explored attitudes toward its applications. Data was collected electronically through LinkedIn and Google Forms, prioritizing anonymity and ethical standards.
Results: Results revealed that 67.3% of participants had experience using ChatGPT, demonstrating a substantial user base among biomedical engineering students. The majority (82%) found ChatGPT to be effective and useful in learning, with 81.4% considering the learning experience through ChatGPT to be attractive. Moreover, nearly half of the participants disagreed with the notion that ChatGPT is solely an informational tool, recognizing its potential as a learning aid. Participants reported pleasant experiences (75%) using ChatGPT for learning, affirming its value in education.
Conclusion: The study underscores ChatGPT's positive impact on learning and productivity for biomedical engineering students. While acknowledging concerns about potential misuse, it suggests ChatGPT holds promise as an educational tool, emphasizing the need for ongoing research to integrate and regulate advanced language models in education.


Main Subjects

Volume 2, Issue 2
Special Issue: Abstract and Papers from ICBMS23 (Turkey), ICBM23 (Hungary), ICCMM23 (Italy)
Pages 161-172
  • Receive Date: 19 December 2023
  • Accept Date: 19 December 2023